fashion -WSS

fashion

author：explore 2025-08-30 08:03:59 - browse：928

Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation. — Suzanne Kreiter/Globe staff

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Texas Medical Board asked to define abortion emergency exception

focus

WSS

Merck, Daiichi strike cancer drug pact worth up to $22 billion

The problems with dementia villages

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Health tech investors get more selective as pandemic boom fades

Why CTE doesn’t keep Americans from enjoying the Super Bowl

knowledge

fashion

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

340B reform proposal comes out of Senate working group

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AstraZeneca stays mum on Medicare drug pricing negotiations

Continuity nursing helped my family in our darkest PICU moments

Global cancer cases to surge 77% by 2050, WHO report says

After affirmative action ruling, medical educators look to 'holistic review'

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Peter Hotez and the public health issue of online harassment

Why CTE doesn’t keep Americans from enjoying the Super Bowl

focus

Readout LOUD podcast: Live from the 2023 STAT Summit

Adopting new red light myopia treatments may be short

STAT Summit: How researchers deal with rejection

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Roche drug slashes death risk in early

A protest over insulin prices is seen as a fight for life

hotspot

entertainment

focus

focus